Blog

When a person suffers a shoulder injury or health complication after a wrongful vaccination, they may be entitled to recover damages. However, there are several collective popular opinions out there about SIRVA claims—many of which are simply untrue. Getting proper guidance is imperative when it comes to you and your future.

Shoulder Injury Related to Vaccine Administration (SIRVA) is a rare complication which occurs when a person is wrongfully vaccinated in the shoulder or upper arm. Thankfully, the affected person may be eligible to pursue damages by filing a SIRVA claim with the National Vaccine Injury Compensation Program (VICP). It’s incredibly important to reach out to an attorney during this challenging time.

Guillain-Barré syndrome (GBS) is a rare neurological illness that occurs when a person’s immune system mistakenly attacks the nerves in their body. The disorder may be triggered by infections, such as the Epstein-Barr virus, Zika virus, or Influenza virus, or after getting vaccinated.

Guillain-Barré syndrome (GBS) is a rare and serious neurological disorder that affects a person’s nerves. Recent reports have shown that several individuals are developing GBS within days or weeks of receiving some vaccines, including Influenza, Epstein-Barr, Zika virus, or COVID-19 vaccines.

We help people who have suffered various neurological disorders following a covered vaccine.  The conditions are autoimmune disorders causing damage

A person who experiences an adverse reaction to a vaccine is not allowed to bring a lawsuit against the company that produced it or against the doctor, nurse, clinic or pharmacy which administered it.

Our attorneys help those who have suffered Guillain-Barré Syndrome (GBS) following the seasonal flu vaccine or influenza vaccine.

A recent study, published in Exploratory Research in Clinical and Social Pharmacy in December 2022, explored the current data regarding SIRVA.

Since 1986, a little-known program of the federal government, called National Vaccine Injury Compensation Program (VICP), has been awarding money to persons suffering from side-effects of certain vaccines.

Prevnar 13 (PCV13) is a pneumococcal conjugate vaccine and was approved for use in 2010. It is recommended for children less than 5, for adults 65 or older, and others with certain medical conditions.